Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs
Pharmaceutical company Pfizer has teamed with investment firm Bain Capital to launch Cerevel Therapeutics – a biopharmaceutical company focused on developing drugs for Parkinson’s and other central nervous system conditions. The new company – which will receive US $350 million of investment from Bain Capital – will begin working on phase three clinical trials on a Parkinson’s drug designed to ... read more
Source: Parkinson’s Life EUPublished on 2018-11-07By admin